A small molecule Smac mimic potentiates TRAIL- and TNFalpha-mediated cell death.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 15353805.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We describe the synthesis and properties of a small molecule mimic of Smac, a pro-apoptotic protein that functions by relieving inhibitor-of-apoptosis protein (IAP)-mediated suppression of caspase activity. The compound binds to X chromosome- encoded IAP (XIAP), cellular IAP 1 (cIAP-1), and cellular IAP 2 (cIAP-2) and synergizes with both tumor necrosis factor alpha (TNFalpha) and TNF-related apoptosis-inducing ligand (TRAIL) to potently induce caspase activation and apoptosis in human cancer cells. The molecule has allowed a temporal, unbiased evaluation of the roles that IAP proteins play during signaling from TRAIL and TNF receptors. The compound is also a lead structure for the development of IAP antagonists potentially useful as therapy for cancer and inflammatory diseases.
Medical subject headings
- Alkynes
- Apoptosis
- Carrier Proteins
- Dipeptides
- Membrane Glycoproteins
- Mitochondrial Proteins
- Molecular Mimicry
- Tetrazoles
- Tumor Necrosis Factor-alpha